Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure) [Original Article]

Conclusions—
In this post hoc analysis of ROSE AHF, the response to vasoactive therapies differed in patients with heart failure with reduced EF and heart failure with preserved EF. Investigations of AHF therapies should assess the potential for differential responses in AHF with preserved versus reduced EF.

Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT01132846.

Source: Circulation: Heart Failure - August 9, 2016 Category: Cardiology Authors: Wan, S.-H., Stevens, S. R., Borlaug, B. A., Anstrom, K. J., Deswal, A., Felker, G. M., Givertz, M. M., Bart, B. A., Tang, W. H. W., Redfield, M. M., Chen, H. H. Tags: Cardiorenal Syndrome, Heart Failure Original Article Source Type: research